Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 11, 2012 - Issue 6
Submit an article Journal homepage
557
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Etanercept-induced injection site reactions: potential pathomechanisms and clinical assessment

Aleksandra Batycka-BaranLudwig-Maximilian University, Department of Dermatology and Allergology, Munich, [email protected];Wroclaw Medical University, Department of Dermatology, Venerology and Allergology, Wroclaw, Poland
, MD, PhD,
Michael FlaigLudwig-Maximilian University, Department of Dermatology and Allergology, Munich, [email protected]
, MD,
Sonja MolinLudwig-Maximilian University, Department of Dermatology and Allergology, Munich, [email protected]
, MD,
Thomas RuzickaLudwig-Maximilian University, Department of Dermatology and Allergology, Munich, [email protected]
, MD &
Joerg C PrinzLudwig-Maximilian University, Department of Dermatology and Allergology, Munich, [email protected]
, MD
Pages 911-921 | Published online: 24 Sep 2012

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Lluís Puig. (2020) The safety of ixekizumab in psoriasis drug therapy. Expert Opinion on Drug Safety 19:2, pages 117-130.
Read now
Eri Hamamura-Yasuno, Tetsuo Aida, Yoshimi Tsuchiya & Kazuhiko Mori. (2020) Immunostimulatory effects on THP-1 cells by peptide or protein pharmaceuticals associated with injection site reactions. Journal of Immunotoxicology 17:1, pages 59-66.
Read now
Priyanka Vashisht & James O’dell. (2017) Not all TNF inhibitors in rheumatoid arthritis are created equal: important clinical differences. Expert Opinion on Biological Therapy 17:8, pages 989-999.
Read now
Chi Chiu Mok, Wen Chan Tsai, Der Yuan Chen & James Cheng Chung Wei. (2016) Immunogenicity of anti-TNF biologic agents in the treatment of rheumatoid arthritis. Expert Opinion on Biological Therapy 16:2, pages 201-211.
Read now

Articles from other publishers (11)

Špela Šuler Baglama & Katarina Trčko. (2021) Cutaneous adverse effects of biologic drugs in psoriasis: a literature review. Acta Dermatovenerologica Alpina Pannonica et Adriatica 30:4.
Crossref
Luca Stingeni, Leonardo Bianchi, Marta Tramontana, Paolo D. Pigatto, Cataldo Patruno, Monica Corazza, Caterina Foti, Gabriella Fabbrocini, Giuseppe Micali, Paolo Romita, Maddalena Napolitano & Katharina Hansel. (2020) Skin tests in the diagnosis of adverse drug reactions. Giornale Italiano di Dermatologia e Venereologia 155:5.
Crossref
Sevim BAVBEK. (2019) TNF-Alfa Inhibitörleri Ile Tedavi Seyrinde Gelişen Alerjik ReaksiyonlarHypersensitivity reactions to TNF-α inhibitors. Ege Tıp Dergisi, pages 1-5.
Crossref
Yidian Dong, Ping Li, Tingshuang Xu & Liqi Bi. (2019) Effective serum level of etanercept biosimilar and effect of antidrug antibodies on drug levels and clinical efficacy in Chinese patients with ankylosing spondylitis. Clinical Rheumatology 38:6, pages 1587-1594.
Crossref
ShrichandG Parasramani & Jisha Pillai. (2019) Biologics in psoriasis: Indian experience. Indian Journal of Drugs in Dermatology 5:1, pages 1.
Crossref
Jeong Yun Choi, Jee Eun Chung, Ji Hyun Park, Yoon Sook Cho, Yong Woo Jung & Soo An Choi. (2018) Surveillance of adverse drug events associated with etanercept prescribed for juvenile idiopathic arthritis in a single center up to 9-years: A retrospective observational study. PLOS ONE 13:11, pages e0204573.
Crossref
Sevim Bavbek & Min Jung Lee. (2017) Subcutaneous Injectable Drugs Hypersensitivity and Desensitization. Immunology and Allergy Clinics of North America 37:4, pages 761-771.
Crossref
Andrés F. Echeverri, Andrés Vidal, Carlos A. Cañas, Andrés Agualimpia, Gabriel J. Tobón & Fabio Bonilla-Abadía. (2015) Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis. Case Reports in Dermatological Medicine 2015, pages 1-2.
Crossref
J.‐M. Carrascosa, M.B.A. van Doorn, M. Lahfa, F.O. Nestle, D. Jullien & J.C. Prinz. (2014) Clinical relevance of immunogenicity of biologics in psoriasis: Implications for treatment strategies. Journal of the European Academy of Dermatology and Venereology 28:11, pages 1424-1430.
Crossref
Jonathan J. Lee & Mai P. Hoang. 2014. Cutaneous Hematopathology. Cutaneous Hematopathology 471 491 .
. (2013) Etanercept. Reactions Weekly 1433:1, pages 20-20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.